Notice of 2018 AGM
Notice of AMEND's 2018 Annual General Meeting which will be held on Saturday 12th May at the NCVO, 8 All Saints St, London N1 9RL from 12:15pm.
April Newsletter Sent to Members
The April newsletter has today been sent out via email to all registered AMEND members. If you would like to receive your free newsletter, simply register for our free membership. This month's edition highlights our new website, updates on Project Rollercoaster and Project Connect and brings you news on all the exciting events and activities planned for 2018 - AMEND's 15th birthday!
UK Research Registry Now Collecting Data
The UK National Research Registry for MEN1 and pancreatic neuroendocrine tumours (pNETs) is now collecting patient data. Patients can sign up to our specific mailing list in order to receive more information shortly about how to notify their specialists to get involved.
MEN1 and pNET Survey Launched
AMEND has launched a new survey today to find out what the patient information needs are of those with MEN1. The short survey takes just 12-15 minutes to complete and will help us raise awareness of patients' needs with the medical profession. Thanks in advance for your help.
Free Patient Event for Sporadic MTC
7th July, 2018 - Central London AMEND will be holding it's first Information Day for all those affected by sporadic (non-hereditary) medullary thyroid cancer (MTC) on Saturday 7th July this year. Thanks to a grant from SanofiGenzyme, the event is free to all patients, family members and carers, although tickets are limited in number. The day will incorporate talks from medical experts and plenty of time to network with fellow patients. Tickets are free including lunch and refreshments.
Please Help With This Important Survey
If you have MEN1, MEN2a, MEN2b or MEN4, the European MEN Alliance (EMENA), of which AMEND is a member, invites you to participate in an important patient survey on Quality of Care throughout Europe. Click to learn more.
Play the Unity Lottery and Support AMEND!
We are delighted to bring you the chance to play the weekly Unity Lottery. There's £25,000 up for grabs every week, and AMEND receives 50% of every £1 spent so the more people who play, the more AMEND receives!
NICE Approves Cabozantinib for Metastatic MTC
Cabozantib, also known as Cometriq, made by Ipsen has been recommended by NICE to come off the Cancer Drugs Fund and into routine use. AMEND was involved in submitting patient opinions into the Appraisal process during 2017.
AMEND awarded Big Lottery Fund grant
Thanks to funding from the UK Big Lottery Fund, AMEND can begin Project Connect, bringing people together for mutual support according to national region.
2018 Annual Patient Information Day
This year's AMEND Patient Information will be held in central London on Saturday 12th May. This event is FREE to patients, friends and families, and includes refreshments, lunch and a creche for those under 12 years of age. This is always a popular event so early booking is advised!
Come climb with us
We are urgently seeking adventurous people to join us on a challenging but fun weekend tackling the Yorkshire 3 Peaks. The event is raising money exclusively for AMEND and is run by Discover Adventure, who organised our 2012 Sahara Trek. If you want a fitness goal and are free on the weekend of 30th June to 1st July, please join us!
Happy Birthday AMEND!
2018 marks the 15th year of AMEND's existence. There's lots going on throughout the year to celebrate our birthday, from special information events to wonderful fundraising challenges. The beginning of the celebrations started with the launch of this, our brand new website. Explore the site and get in touch if you would like to get involved!